Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
29 févr. 2024 08h01 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
29 févr. 2024 08h00 HE
|
Achieve Life Sciences
$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds to provide funds to conduct clinical development of...
Nicotine Replacement Therapy Market Insights, Competitive Landscape, and Market Forecast to 2030
28 févr. 2024 12h18 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Nicotine Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Global Substance Abuse Disorder Treatment Research Analysis Report 2024: Public and Private Entities Join Forces to Tackle Substance Abuse Epidemic - Forecasts to 2034
31 janv. 2024 09h44 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Substance Abuse Disorder Treatment Market Analysis & Forecast 2024-2034: Market By Treatment; By End-user; and By Region" report has been...
Smoking Cessation Aids Market in the US Undergoes Major Shift Towards Oral NRT Options
28 janv. 2024 19h43 HE
|
Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "NRT Smoking Cessation Aids in the US" report has been added to ResearchAndMarkets.com's offering.NRT patches is set to continue to witness steep...
Nicotine Addiction Treatment Market Report 2024: Major Companies Innovate to Dominate - Long-term Forecast to 2028 and 2033
24 janv. 2024 07h38 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Nicotine Addiction Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Expansion of Nicotine...
OTC Drugs & Dietary Supplements Market Report 2024-2034 - Pharmaceutical Companies Increasingly Switching from Rx to OTC Drugs
24 janv. 2024 04h18 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "OTC Drugs & Dietary Supplements Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for OTC Drugs &...
Global Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report 2023-2030: Focus on Nicotine Replacement Therapy, E-cigarettes, Heat-not-burn Tobacco Products
05 janv. 2024 08h38 HE
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Nicotine Replacement Therapy, E-cigarettes,...
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
11 déc. 2023 16h30 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Smoking Cessation Market to Grow at a Substantial Growth Rate During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Axsome Therapeutics, Achieve Life Sciences, Chronic Airway Therapeutics, Smoke Free Therapeutics
30 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Smoking Cessation Market to Grow at a Substantial Growth Rate During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Axsome...